This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2016

Primary Completion Date

June 15, 2017

Study Completion Date

September 22, 2017

Conditions

Psoriasis

Interventions

DRUG

Caffeine

DRUG

Warfarin

DRUG

Omeprazole

DRUG

Metoprolol

DRUG

Midazolam

DRUG

Risankizumab

Trial Locations (1)

Boehringer Ingelheim Investigational Site, Berlin